Phytochemicals from MO demonstrated strong interactions with HIF-1α (hypoxia-inducible factor 1-alpha), VEGF, and GLUT1 receptors, showing favorable pharmacokinetics and potential as breast cancer inhibitors [260]. Here, HIF1A is linked to breast carcinoma.